Literature DB >> 20364412

Update on the role of Toll-like receptors during bacterial infections and sepsis.

Sylvia Knapp1.   

Abstract

Toll-like receptors (TLRs) are recognition molecules that importantly contribute to the innate immune response to bacterial and viral infections. Once TLRs sense the presence of invading pathogens a signal transduction cascade is initiated that eventually leads to the production of pro-inflammatory mediators and attraction of neutrophils to the site of infection. While the ultimate goal of this defense pathway is the successful elimination of invading microbes, prolonged or exaggerated stimulation of TLR-associated events can lead to systemic inflammation and clinical symptoms of sepsis. This brief review summarizes the impact of selected TLRs in the host response to clinically important bacteria and provides insights into TLR-associated therapeutic approaches during sepsis and inflammation.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20364412     DOI: 10.1007/s10354-010-0765-6

Source DB:  PubMed          Journal:  Wien Med Wochenschr        ISSN: 0043-5341


  41 in total

Review 1.  Toll-like receptors and innate immunity.

Authors:  R Medzhitov
Journal:  Nat Rev Immunol       Date:  2001-11       Impact factor: 53.106

2.  Differential roles of CD14 and toll-like receptors 4 and 2 in murine Acinetobacter pneumonia.

Authors:  Sylvia Knapp; Catharina W Wieland; Sandrine Florquin; Ralph Pantophlet; Lenie Dijkshoorn; Ntambua Tshimbalanga; Shizuo Akira; Tom van der Poll
Journal:  Am J Respir Crit Care Med       Date:  2005-10-06       Impact factor: 21.405

3.  Secreted MD-2 is a large polymeric protein that efficiently confers lipopolysaccharide sensitivity to Toll-like receptor 4.

Authors:  A Visintin; A Mazzoni; J A Spitzer; D M Segal
Journal:  Proc Natl Acad Sci U S A       Date:  2001-10-02       Impact factor: 11.205

4.  Surviving Sepsis Campaign: international guidelines for management of severe sepsis and septic shock: 2008.

Authors:  R Phillip Dellinger; Mitchell M Levy; Jean M Carlet; Julian Bion; Margaret M Parker; Roman Jaeschke; Konrad Reinhart; Derek C Angus; Christian Brun-Buisson; Richard Beale; Thierry Calandra; Jean-Francois Dhainaut; Herwig Gerlach; Maurene Harvey; John J Marini; John Marshall; Marco Ranieri; Graham Ramsay; Jonathan Sevransky; B Taylor Thompson; Sean Townsend; Jeffrey S Vender; Janice L Zimmerman; Jean-Louis Vincent
Journal:  Crit Care Med       Date:  2008-01       Impact factor: 7.598

5.  Defective LPS signaling in C3H/HeJ and C57BL/10ScCr mice: mutations in Tlr4 gene.

Authors:  A Poltorak; X He; I Smirnova; M Y Liu; C Van Huffel; X Du; D Birdwell; E Alejos; M Silva; C Galanos; M Freudenberg; P Ricciardi-Castagnoli; B Layton; B Beutler
Journal:  Science       Date:  1998-12-11       Impact factor: 47.728

6.  Role of Toll-like receptor 4 in gram-positive and gram-negative pneumonia in mice.

Authors:  Judith Branger; Sylvia Knapp; Sebastiaan Weijer; Jaklien C Leemans; Jennie M Pater; Peter Speelman; Sandrine Florquin; Tom van der Poll
Journal:  Infect Immun       Date:  2004-02       Impact factor: 3.441

7.  Recognition of pneumolysin by Toll-like receptor 4 confers resistance to pneumococcal infection.

Authors:  Richard Malley; Philipp Henneke; Sarah C Morse; Michael J Cieslewicz; Marc Lipsitch; Claudette M Thompson; Evelyn Kurt-Jones; James C Paton; Michael R Wessels; Douglas T Golenbock
Journal:  Proc Natl Acad Sci U S A       Date:  2003-02-04       Impact factor: 11.205

Review 8.  Toll-like receptors.

Authors:  Kiyoshi Takeda; Tsuneyasu Kaisho; Shizuo Akira
Journal:  Annu Rev Immunol       Date:  2001-12-19       Impact factor: 28.527

Review 9.  A cell biological view of Toll-like receptor function: regulation through compartmentalization.

Authors:  Gregory M Barton; Jonathan C Kagan
Journal:  Nat Rev Immunol       Date:  2009-06-26       Impact factor: 53.106

10.  Identification of oxidative stress and Toll-like receptor 4 signaling as a key pathway of acute lung injury.

Authors:  Yumiko Imai; Keiji Kuba; G Greg Neely; Rubina Yaghubian-Malhami; Thomas Perkmann; Geert van Loo; Maria Ermolaeva; Ruud Veldhuizen; Y H Connie Leung; Hongliang Wang; Haolin Liu; Yang Sun; Manolis Pasparakis; Manfred Kopf; Christin Mech; Sina Bavari; J S Malik Peiris; Arthur S Slutsky; Shizuo Akira; Malin Hultqvist; Rikard Holmdahl; John Nicholls; Chengyu Jiang; Christoph J Binder; Josef M Penninger
Journal:  Cell       Date:  2008-04-18       Impact factor: 41.582

View more
  13 in total

1.  Editorial: sepsis.

Authors:  Sylvia Knapp; Michael Frass
Journal:  Wien Med Wochenschr       Date:  2010-03

2.  Triaryl Pyrazole Toll-Like Receptor Signaling Inhibitors: Structure-Activity Relationships Governing Pan- and Selective Signaling Inhibitors.

Authors:  Julie A Pollock; Naina Sharma; Sirish K Ippagunta; Vanessa Redecke; Hans Häcker; John A Katzenellenbogen
Journal:  ChemMedChem       Date:  2018-09-13       Impact factor: 3.466

3.  Toll-like receptor 2 in serum: a potential diagnostic marker of prosthetic joint infection?

Authors:  Emanuela Galliera; Lorenzo Drago; Christian Vassena; Carlo Romanò; Monica Gioia Marazzi; Lucia Salcito; Massimiliano M Corsi Romanelli
Journal:  J Clin Microbiol       Date:  2013-11-13       Impact factor: 5.948

4.  Identification of Toll-like receptor signaling inhibitors based on selective activation of hierarchically acting signaling proteins.

Authors:  Sirish K Ippagunta; Julie A Pollock; Naina Sharma; Wenwei Lin; Taosheng Chen; Kazuki Tawaratsumida; Anthony A High; Jaeki Min; Yizhe Chen; R Kiplin Guy; Vanessa Redecke; John A Katzenellenbogen; Hans Häcker
Journal:  Sci Signal       Date:  2018-08-14       Impact factor: 8.192

5.  Targeting Toll-like receptor (TLR) signaling by Toll/interleukin-1 receptor (TIR) domain-containing adapter protein/MyD88 adapter-like (TIRAP/Mal)-derived decoy peptides.

Authors:  Leah A Couture; Wenji Piao; Lisa W Ru; Stefanie N Vogel; Vladimir Y Toshchakov
Journal:  J Biol Chem       Date:  2012-05-30       Impact factor: 5.157

Review 6.  Toll-Like Receptor Activation in Immunity vs. Tolerance in Autoimmune Diabetes.

Authors:  Elke Gülden; Li Wen
Journal:  Front Immunol       Date:  2014-03-24       Impact factor: 7.561

7.  Corilagin ameliorates the extreme inflammatory status in sepsis through TLR4 signaling pathways.

Authors:  Hua-Rong Li; Jie Liu; Shu-Ling Zhang; Tao Luo; Fei Wu; Ji-Hua Dong; Yuan-Jin Guo; Lei Zhao
Journal:  BMC Complement Altern Med       Date:  2017-01-05       Impact factor: 3.659

8.  Expression of Toll-like receptors (TLRs) in the lungs of an experimental sepsis mouse model.

Authors:  Anargyros Bakopoulos; Alkistis Kapelouzou; Diamantis I Tsilimigras; Michalis Katsimpoulas; Dimitrios Schizas; Chrysostomos Aravanis; Evaggelos Balafas; Manolis Mavroidis; Kitty Pavlakis; Anastasios Machairas; Theodore Liakakos
Journal:  PLoS One       Date:  2017-11-14       Impact factor: 3.240

9.  Effects of Pseudomonas aeruginosa and Streptococcus mitis mixed infection on TLR4-mediated immune response in acute pneumonia mouse model.

Authors:  Chao Song; Hongdong Li; Yunhui Zhang; Jialin Yu
Journal:  BMC Microbiol       Date:  2017-04-04       Impact factor: 3.605

Review 10.  Cellular and viral microRNAs in sepsis: mechanisms of action and clinical applications.

Authors:  Dana Elena Giza; Enrique Fuentes-Mattei; Marc David Bullock; Stefan Tudor; Matthew Joseph Goblirsch; Muller Fabbri; Florea Lupu; Sai-Ching Jim Yeung; Catalin Vasilescu; George Adrian Calin
Journal:  Cell Death Differ       Date:  2016-10-14       Impact factor: 15.828

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.